Wang Haifeng, Wright Cameron D, Wain John C, Ott Harald C, Mathisen Douglas J
Massachusetts General Hospital, Boston, Massachusetts; Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Massachusetts General Hospital, Boston, Massachusetts.
Ann Thorac Surg. 2015 Nov;100(5):1804-11. doi: 10.1016/j.athoracsur.2015.05.079. Epub 2015 Aug 18.
Idiopathic subglottic stenosis is a rare inflammatory condition affecting the subglottic larynx. We have treated 263 patients (only 2 were male) with this condition. The purpose of this study is to determine factors affecting outcome and predisposing to complications.
Information was gathered from chart reviews, surveys, and a prospective database.
Median time from diagnosis to surgery was 24 months. Antinuclear antibodies when measured were positive in 76 patients (47%). Prior tracheal procedures were done in 58 patients (22%), and 184 patients (70%) had prior endoscopic procedures. Resection of the posterior cricoid mucosa with tracheal membranous wall flap was done in 150 patients (57%). Tailored cricoplasty was performed in 105 patients (40%). Extubation in the operating room was achieved in 247 patients (94%). Steroid therapy for edema was required in 63 patients (24%). Anastomotic complications occurred in 30 patients, 17 granulations and 7 subcutaneous air. Twenty-three patients (8.7%) have recurrence (14 mild, 9 recalcitrant) requiring dilation. Risk factors for anastomotic complications and recurrence were edema requiring steroids, use of mitomycin C, and prior tracheostomy, stents, and vocal cord involvement. Follow-up was available for 227 patients. Follow-up survey of 180 patients revealed, on a 10-point scale, effectiveness 9.4, satisfaction 9.4, and symptom improvement 9.4. A normal voice was present in 82 patients (45%); 96 patients (54%) had change in voice; and 121 patients (67%) had difficulty projecting their voice.
Single-stage reconstructive surgery resulted in 96% good-to-excellent results. Recalcitrant stenosis developed in 4% of patients. Stents, postoperative edema, mitomycin use, and vocal cord involvement are risks for recurrence. Recurrence was related to reactivation of disease in 14 patients and to technical problems in 6 patients.
特发性声门下狭窄是一种影响声门下喉部的罕见炎症性疾病。我们已治疗263例患有这种疾病的患者(仅2例为男性)。本研究的目的是确定影响预后和易引发并发症的因素。
从病历回顾、调查和前瞻性数据库中收集信息。
从诊断到手术的中位时间为24个月。检测时抗核抗体在76例患者(47%)中呈阳性。58例患者(22%)曾接受过气管手术,184例患者(70%)曾接受过内镜手术。150例患者(57%)进行了环状软骨后黏膜切除及气管膜壁瓣修复。105例患者(40%)进行了定制环状软骨成形术。247例患者(94%)在手术室实现了拔管。63例患者(24%)因水肿需要类固醇治疗。30例患者出现吻合口并发症,17例有肉芽组织,7例有皮下气肿。23例患者(8.7%)复发(14例轻度,9例顽固性)需要扩张。吻合口并发症和复发的危险因素包括需要类固醇治疗的水肿、丝裂霉素C的使用以及既往气管切开术、支架置入和声带受累。227例患者可进行随访。对180例患者的随访调查显示,在10分制中,有效性为9.4分,满意度为9.4分,症状改善为9.4分。82例患者(45%)声音正常;96例患者(54%)声音有变化;121例患者(67%)发声困难。
一期重建手术取得了96%的良好至优秀效果。4%的患者出现顽固性狭窄。支架置入、术后水肿、丝裂霉素的使用和声带受累是复发的风险因素。14例患者的复发与疾病再激活有关,6例与技术问题有关。